Volunteer by completing the questionnaire below
Studies that involve new medications or new vaccines have strict rules about who can take part. Therefore, we need to collect some information about you to help us understand whether you will be able to participate in this study.
VLA2001-301 will be a clinical study testing a new vaccine candidate (VLA2001) to prevent COVID-19. We will evaluate this investigational product against AZD1222, the COVID-19 vaccine developed by AstraZeneca and approved for use by the UK authorities. Valneva Austria GmbH is the Sponsor of this study and Pharm Olam LLC is the company supporting Valneva in performing the trial in the UK.
e are committed to protecting and respecting your privacy. For general information on how Valneva Austria GmbH processes your personal data in relation to this website, please see our Privacy Notice.
By clicking the "Next" button on the form, you consent to allow Valneva Austria GmbH to store and process the personal information and the answers to the questionnaire submitted to determine your potential eligibility for this study and submit the data to the participating NHS study site.
Please complete the following questionnaire and find out if you qualify for trial participation:
(This helps us route you to the correct participating NHS facility)
Please select a location...
Thank you for your interest
Due to a high number of responses, we might not be able to get back to everyone—if you do not hear from us, then we are unable to offer you participation in this trial.
Thank you for taking the time to complete this pre-screening questionnaire.
Unfortunately, you are not eligible for this trial, however we are very grateful for your interest.
If you find you are unable to take part for any reason, this is not necessarily a reflection of your health or whether you could have a COVID-19 vaccine in the future.
For more information about Valneva and their COVID-19 vaccine candidate please refer to https://valneva.com/research-development/covid-19-vla2001/